In the field of CAR T-cell treatment, the First Affiliated Hospital of Zhengzhou University, situated in Zhengzhou, China, has become a well-known organisation. The hospital has made tremendous progress in maximising the potential of CAR T-cell therapy for patients by placing a major emphasis on cutting-edge cancer treatments. Oncologists, immunologists, geneticists, and other members of their interdisciplinary medical staff have all taken an active part in studies and clinical trials. The facility has treated haematological malignancies with impressive success thanks to the use of CAR T-cell therapy. As personalised cancer therapy develops, The First Affiliated Hospital of Zhengzhou University is in the forefront, giving patients fresh hope and a better quality of life.
- Established_In 1928
- Hospital_Grade Top three general hospital
Specialities
